AIL altered the microenvironment of BC bone metastases by upregulating FOXP3 expression in BC cells, and then inhibited osteoclast formation induced by the BC-CM through NF-κB, MAPK and PI3K/AKT signaling pathways. Here, AKT1 is linked to breast cancer.